RPTH Journal/LinkedIn
Nov 9, 2025, 10:18
RPTH Study Finds 3× Cancer Risk in Migraine Patients After VTE
RPTH Journal posted on LinkedIn:
”Patients with migraines have a higher risk of venous clots.
Oscar Rosenkrantz and team examined if cancer risk after clot was still elevated. They found in a Danish cohort that risk was 3x higher in year one vs expected rates, suggesting occult cancer may still explain clots.
Read the study here.
Title: Venous thromboembolism and cancer risk in patients with a history of migraine: a population-based cohort study
Authors: Oscar Rosenkrantz, Dóra K. Farkas, Erzsébet Horváth-Puhó, Søren K. Martiny, Holly Elser, Cecilia H. Fuglsang, Henrik T. Sørensen”
Stay updated with Hemostasis Today.
Blood Clots
cancer
Cancer Risk
Cecilia H. Fuglsang
Dóra K. Farkas
Erzsébet Horváth-Puhó
Health
Hematology
Hemostasis
Hemostasis Today
Henrik T. Sørensen
Holly Elser
International Society on Thrombosis and Haemostasis
ISTH
Medicine
Migraine
Oscar Rosenkrantz
rpth
RPTH Journal
Søren K. Martiny
thrombosis
venous thromboembolism
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy